Search results
3 days ago · As of March 25, 2023, the CDC reports that 89.1% of Latinos in the United States have received at least one dose of the COVID-19 vaccine. This vaccination rate is slightly higher than the 87.0% rate among non-Latino White Americans and similar to the 89.2% rate among African Americans [ 6 ]. Asian Americans, meanwhile, have the highest ...
- An mRNA vaccine for pancreatic cancer designed by applying
Recently, Pfizer and BioNTech developed an mRNA neoantigen...
- An mRNA vaccine for pancreatic cancer designed by applying
19 hours ago · Recently, Pfizer and BioNTech developed an mRNA neoantigen vaccine against PDAC. The vaccine is based on uridine mRNA-lipoplex nanoparticles, demonstrating a substantial efficacy level in the phase I clinical trial . However, this study is the first endeavor to develop an in silico-based mRNA vaccine for pancreatic cancer. Therefore, this study ...
Jun 27, 2024 · On October 6, 2021, the World Health Organization (WHO) recommended the first vaccine against malaria to prevent Plasmodium falciparum malaria in children living in areas with moderate to high transmission [1], a watershed moment in child health.
Jun 25, 2024 · The vaccine consisted of GBP510 and an AS03 adjuvant. GBP510 is a self-assembling two-component protein virus-like particle based on the I53–50 carrier, which contains 60 copies of the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein. The RBD-I53–50A fusion protein is expressed in mammalian cells.
Jun 30, 2024 · A viral vector vaccine, it’s based on murine pneumonia virus. The developers have published 2 preclinical studies for this vaccine, both in primates. The first study tested a single dose in macaques.
Jun 29, 2024 · With its unique properties and potential applications, nanoparticle-based delivery platforms for messenger RNA (mRNA) vaccines have gained significant attention in recent years. Nanoparticles have the advantages of enhancing immunogenicity, targeting delivery, and improving stability, providing a new solution for drug and vaccine delivery. In some clinical studies, a variety of nanoparticle ...
Jul 1, 2024 · The Vaccine Effectiveness, Burden and Impact Studies (VEBIS) of COVID-19 and influenza, funded by the European Centre for Disease Prevention and Control, is a multicenter case-control study that collects data from 11 European sites: Croatia; France; Germany; Hungary; Ireland; Portugal; the Netherlands; Romania; Spain, national; Spain, Navarre region; and Sweden. 15 The VEBIS primary care ...
